WednesdayNov 18, 2026 9:50 am

QualityStocksNewsBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Reports $2.89 Million in Q3 Revenue Following Technology Business Transition

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) reported financial results for the third quarter ended Sept. 30, 2026, including revenue of $2.89 million, compared with no revenue a year earlier, marking its first full quarter of revenue from its technology business. The company generated $2.48 million from software development and deployment services for two enterprise customers, including one related party. Operating income totaled $2 million, while net income reached $33.6 million, or $19.13 per basic share, including a $25.26 million unrealized gain on digital assets. Total assets stood at $153.5 million, with shareholders' equity of $140.5 million. Apimeds completed its…

Continue Reading

MondayNov 16, 2026 10:50 am

QualityStocksNewsBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Subsidiary MindWave Innovations Announces $NILA Token Trading on PICOL in South Korea

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS), through its wholly owned subsidiary MindWave Innovations Inc. USA, announced that $NILA, the native token of the MindChain network, began trading on PICOL, a cryptocurrency trading platform serving South Korean users, on Nov. 16, 2026, at 8:30 a.m. Eastern. Trading is available through the NILA/USDT pair, providing eligible users access to the token through manual trading and automated trading tools. The listing marks $NILA's first exchange listing focused on South Korea and expands its existing availability on Webot, LBank, Biconomy and Pionex. MindWave is developing MindChain, an Ethereum-based Layer 2 network designed to…

Continue Reading

MondayNov 16, 2026 9:45 am

MindWave Innovations Inc. (NYSE American: APUS) Targets the Infrastructure Behind Institutional Asset Tokenization

Institutional tokenization requires more than issuance, creating demand for infrastructure supporting custody, compliance, ownership records and asset management. MindWave is developing an RWA ecosystem designed to support assets throughout their lifecycle, from onboarding and legal structuring to reporting and transfers. Its Nexus Global Partners application targets institutional real estate, extending MindWave’s broader blockchain infrastructure strategy into the expanding tokenized asset market. Tokenizing an asset and putting it on a blockchain may be the most visible part of the real-world asset (“RWA”) opportunity, but it is far from the end of the process. For institutional investors, the challenge extends well beyond…

Continue Reading

MondayNov 09, 2026 9:30 am

QualityStocksNewsBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Subsidiary MindWave Enters Joint Venture Agreement to Establish Bermuda Insurance Business

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced that its wholly owned subsidiary, MindWave Innovations Inc. USA, has entered into a shareholders and joint venture agreement with Singapore-based Skalup Capital Pte Ltd to establish an insurance and technology business in Bermuda under the working brand Monaco Insurance, subject to regulatory approval. Under the agreement, MindWave will hold 75% of the venture's common equity, while Skalup will hold 25%. The proposed business will combine MindWave's blockchain infrastructure and digital-asset-backed capital through staking with Skalup's underwriting expertise and regulatory support. The venture plans to pursue licensing from the Bermuda Monetary Authority ("BMA"),…

Continue Reading

FridayNov 06, 2026 9:45 am

Apimeds’ MindWave Innovations Expands MindChain Across Climate Finance, Sports Media and Insurance

MindWave signed three network agreements spanning climate finance, sports media and insurance within 10 days. The agreements combine infrastructure development and technical services with potential equity or token allocations. The deals highlight MindWave’s strategy of extending a shared blockchain foundation into industry-specific applications. Apimeds Pharmaceuticals US Inc., through its wholly owned subsidiary MindWave Innovations Inc. (NYSE American: APUS), is expanding its blockchain infrastructure strategy through three agreements covering climate finance, sports media and insurance. The agreements extend MindChain into distinct industry applications while reinforcing MindWave’s focus on building and operating dedicated networks for real-world business workflows. Rather than developing separate…

Continue Reading

WednesdayNov 04, 2026 9:00 am

MindWave Innovations Inc. (NYSE American: APUS) Builds Institutional Digital Asset Infrastructure Beyond Blockchain Security

MindWave is developing an integrated infrastructure model combining digital asset treasury, validator operations, insurance innovation, and real-world asset tokenization. Its MindChain Layer 2 and validator infrastructure are designed to complement technical security with institutional risk management and protection. New agreements to build and operate AssureChain and AQUAEChain demonstrate how MindChain can serve as infrastructure for specialized institutional networks. For institutions entering the digital asset economy, blockchain security is only one part of the risk equation. Audits, validator monitoring, secure custody and infrastructure controls can lower the risk of technical and operational failures, but they do not necessarily address what happens…

Continue Reading

TuesdayNov 03, 2026 9:10 am

QualityStocksNewsBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Subsidiary MindWave Innovations Featured in CryptoCurrencyWire Podcast

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) through its wholly owned subsidiary MindWave Innovations Inc., is featured in the latest CryptoCurrencyWire Audio Production released by IBN. During the interview with IBN's Carmel Fisher, MindWave CEO Dr. Vin Menon discusses the development of MindChain, an institutional blockchain platform designed to combine digital asset infrastructure with insurance protection. Menon outlines the subsidiary's efforts to establish enterprise blockchain ecosystems across multiple industries, including climate technology, media and advertising, and insurance. These initiatives include a ClimateTech partnership with AQUAE Impact, an AdTech agreement involving a Nasdaq-listed company and an InsurTech ecosystem under development to…

Continue Reading

FridayOct 23, 2026 3:26 pm

QualityStocksNewsBreaks – MindWave Innovations Inc. (NYSE American: APUS) Leveraging Four-Part Ecosystem with MindChain at Its Core

MindWave Innovations (NYSE American: APUS) was featured in a recent article that discussed how growing blockchain adoption is increasing demand for specialized infrastructure to support complex digital asset applications and how the company is positioning itself in this evolving market. “Rather than building around a single application or token, MindWave’s newly defined ecosystem is structured around four interconnected components: MindWave as the infrastructure provider, MindChain as the underlying blockchain, MindWaveDAO as the community and governance layer, and $NILA as the utility and governance token,” the publication reads. “At the center is MindChain, an EVM-compatible Layer 2 designed to serve as…

Continue Reading

TuesdayOct 13, 2026 10:20 am

QualityStocksNewsBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Announces MindWave NILA Token Listing on Pionex Exchange

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced that NILA, the native utility and governance token of the MindChain network developed by its wholly owned subsidiary, MindWave Innovations Inc. USA, is scheduled to begin trading on the Pionex cryptocurrency exchange Oct. 14, 2026, at 6 a.m. Eastern time. The listing will make NILA available to eligible users through the NILA/USDT trading pair, with access to Pionex's standard trading features and automated trading tools. The listing expands international access to NILA ahead of its planned migration to MindChain, an Ethereum-based Layer 2 network designed to support enterprise blockchain applications. MindWave has…

Continue Reading

MondayOct 12, 2026 9:00 am

QualityStocksNewsBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Subsidiary MindWave Innovations Signs Three Blockchain Network Agreements Across Three Industries

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) through its wholly owned subsidiary MindWave Innovations Inc. USA, announced that MindWave signed three agreements between Sept. 24 and Oct. 4, 2026, to build and operate dedicated blockchain networks on its MindChain infrastructure for clients in climate finance, sports media and insurance. The agreements include Singapore-based AQUAE Holdings for its AQUAEChain environmental credit platform, New York-based Flash Sports & Media Holdings for its FlashChain digital ticketing and media authentication network and Delaware-based BlockAssure for its AssureChain insurance and reinsurance network. Under the agreements, MindWave will receive contracted fees or equity along with allocations…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered